Methode Ele Financials
This page shows Methode Ele (MEI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Methode’s margin collapse left a still-liquid balance sheet supporting a business where reinvestment now outruns internal cash generation.
From FY2023 to FY2025, revenue slipped only11.1% , but gross profit fell38.1% ; that gap says the damage came more from thinner unit economics than from lost sales alone. By FY2025, gross profit of$163.4M no longer covered the combined SG&A and R&D spend of$205.7M , so the operating loss was rooted in the cost structure rather than just below-the-line charges.
The company still produced positive operating cash flow of
Debt-to-equity rose from 0.4x in FY2023 to 0.5x in FY2025 even though long-term debt was broadly flat, which means equity erosion rather than new borrowing made the capital structure tighter. Liquidity is still decent with a current ratio of 2.5x, but the same debt load now sits on a thinner equity cushion.
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Methode Ele's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Methode Ele has an operating margin of 0.9%, meaning the company retains $1 of operating profit per $100 of revenue. This below-average margin results in a low score of 24/100, suggesting thin profitability after operating expenses. This is up from -2.3% the prior year.
Methode Ele's revenue declined 2.8% year-over-year, from $1.0B to $1.0B. This contraction results in a growth score of 19/100.
Methode Ele has elevated debt relative to equity (D/E of 0.48), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 23/100, reflecting increased financial risk.
With a current ratio of 2.37, Methode Ele holds $2.37 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 66/100.
Methode Ele's free cash flow margin of 1.5% results in a low score of 29/100. Capital expenditures of $22.4M absorb a large share of operating cash flow.
Methode Ele generates a -5.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 23/100. This is up from -9.1% the prior year.
Methode Ele scores 2.17, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Methode Ele passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Methode Ele generates $-1.06 in operating cash flow ($38.0M OCF vs -$35.7M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Methode Ele earns $0.4 in operating income for every $1 of interest expense ($8.8M vs $23.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Methode Ele generated $1.0B in revenue in fiscal year 2026. This represents a decrease of 2.8% from the prior year.
Methode Ele's EBITDA was $67.6M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 95.4% from the prior year.
Methode Ele reported -$35.7M in net income in fiscal year 2026. This represents an increase of 43.0% from the prior year.
Methode Ele earned $-1.01 per diluted share (EPS) in fiscal year 2026. This represents an increase of 42.9% from the prior year.
Cash & Balance Sheet
Methode Ele generated $15.6M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 202.6% from the prior year.
Methode Ele held $139.6M in cash against $324.8M in long-term debt as of fiscal year 2026.
Methode Ele paid $0.22 per share in dividends in fiscal year 2026. This represents a decrease of 60.7% from the prior year.
Methode Ele had 35M shares outstanding in fiscal year 2026. This represents an increase of 0.8% from the prior year.
Margins & Returns
Methode Ele's gross margin was 19.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 4.2 percentage points from the prior year.
Methode Ele's operating margin was 0.9% in fiscal year 2026, reflecting core business profitability. This is up 3.1 percentage points from the prior year.
Methode Ele's net profit margin was -3.5% in fiscal year 2026, showing the share of revenue converted to profit. This is up 2.5 percentage points from the prior year.
Methode Ele's ROE was -5.3% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 3.8 percentage points from the prior year.
Capital Allocation
Methode Ele invested $37.5M in research and development in fiscal year 2026. This represents a decrease of 10.3% from the prior year.
Methode Ele spent $0 on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.
Methode Ele invested $22.4M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 46.2% from the prior year.
MEI Income Statement
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | $233.7M-5.3% | $246.9M+2.7% | $240.5M-12.6% | $275.1M+14.7% | $239.9M-18.0% | $292.6M+13.2% | $258.5M |
| Cost of Revenue | N/A | $194.9M-2.2% | $199.2M+1.1% | $197.0M-22.6% | $254.4M+28.1% | $198.6M-15.4% | $234.7M+9.7% | $213.9M |
| Gross Profit | N/A | $38.8M-18.7% | $47.7M+9.7% | $43.5M+110.1% | $20.7M-49.9% | $41.3M-28.7% | $57.9M+29.8% | $44.6M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | $39.1M+0.3% | $39.0M+6.6% | $36.6M-22.1% | $47.0M+24.7% | $37.7M-11.5% | $42.6M-7.8% | $46.2M |
| Operating Income | N/A | -$6.1M-310.3% | $2.9M+163.6% | $1.1M+103.4% | -$32.2M-1363.6% | -$2.2M-123.4% | $9.4M+225.3% | -$7.5M |
| Interest Expense | N/A | -$5.4M+5.3% | -$5.7M+3.4% | -$5.9M-34.1% | -$4.4M+20.0% | -$5.5M+11.3% | -$6.2M-29.2% | -$4.8M |
| Income Tax | N/A | $2.8M-50.9% | $5.7M+35.7% | $4.2M+481.8% | -$1.1M-117.7% | $6.2M+93.8% | $3.2M-38.5% | $5.2M |
| Net Income | N/A | -$15.9M-60.6% | -$9.9M+3.9% | -$10.3M+71.6% | -$36.3M-152.1% | -$14.4M-800.0% | -$1.6M+91.3% | -$18.3M |
| EPS (Diluted) | N/A | $-0.45-60.7% | $-0.28+3.4% | $-0.29 | N/A | $-0.41-720.0% | $-0.05+90.4% | $-0.52 |
MEI Balance Sheet
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.3B0.0% | $1.3B+1.5% | $1.3B-0.3% | $1.3B-1.1% | $1.3B+0.1% | $1.3B-5.1% | $1.4B-0.2% | $1.4B |
| Current Assets | $600.0M+2.5% | $585.3M+5.4% | $555.3M+1.1% | $549.2M-1.9% | $559.9M-2.1% | $572.2M-6.6% | $612.9M+0.2% | $611.8M |
| Cash & Equivalents | $139.6M+4.4% | $133.7M+12.8% | $118.5M-2.1% | $121.1M+16.9% | $103.6M-0.2% | $103.8M+7.0% | $97.0M-12.8% | $111.3M |
| Inventory | $178.7M-14.8% | $209.8M+10.3% | $190.2M-0.4% | $190.9M-1.6% | $194.1M-11.3% | $218.8M-4.1% | $228.2M+3.8% | $219.9M |
| Accounts Receivable | $257.3M+19.3% | $215.6M-6.1% | $229.6M+6.5% | $215.6M-10.5% | $241.0M+9.5% | $220.0M-14.0% | $255.9M+2.9% | $248.6M |
| Goodwill | $174.9M-0.3% | $175.5M+1.2% | $173.4M-0.3% | $173.9M+0.7% | $172.7M+3.2% | $167.4M-1.8% | $170.4M-0.1% | $170.6M |
| Total Liabilities | $628.6M-0.4% | $631.3M+3.8% | $608.1M+0.8% | $603.2M-1.5% | $612.5M+2.0% | $600.3M-5.7% | $636.8M+0.5% | $633.5M |
| Current Liabilities | $253.5M+4.4% | $242.8M+11.6% | $217.6M-0.9% | $219.6M-5.8% | $233.2M+15.8% | $201.4M-9.5% | $222.6M-14.6% | $260.8M |
| Long-Term Debt | $324.8M-4.7% | $340.7M+2.5% | $332.3M+2.8% | $323.2M+1.8% | $317.4M-3.1% | $327.7M-3.7% | $340.4M+15.1% | $295.8M |
| Total Equity | $677.5M+0.4% | $675.0M-0.6% | $679.3M-1.3% | $688.1M-0.8% | $693.3M-1.6% | $704.3M-4.6% | $738.3M-0.8% | $744.4M |
| Retained Earnings | $479.3M-0.4% | $481.0M-3.6% | $498.9M-2.4% | $511.0M-2.5% | $524.2M-6.1% | $558.3M-3.8% | $580.6M-1.1% | $587.1M |
MEI Cash Flow Statement
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.9M-68.2% | $15.4M+308.1% | -$7.4M-129.5% | $25.1M-29.1% | $35.4M+26.0% | $28.1M+158.5% | -$48.0M-540.4% | $10.9M |
| Capital Expenditures | $5.8M+9.4% | $5.3M+26.2% | $4.2M-40.8% | $7.1M-22.0% | $9.1M+7.1% | $8.5M-18.3% | $10.4M-23.5% | $13.6M |
| Free Cash Flow | -$900K-108.9% | $10.1M+187.1% | -$11.6M-164.4% | $18.0M-31.6% | $26.3M+34.2% | $19.6M+133.6% | -$58.4M-2063.0% | -$2.7M |
| Investing Cash Flow | $14.9M+463.4% | -$4.1M-10.8% | -$3.7M+36.2% | -$5.8M+6.5% | -$6.2M-8.8% | -$5.7M+23.0% | -$7.4M+45.6% | -$13.6M |
| Financing Cash Flow | -$15.2M-623.8% | -$2.1M-127.6% | $7.6M+268.9% | -$4.5M+89.4% | -$42.3M-397.6% | -$8.5M-121.2% | $40.1M+183.2% | -$48.2M |
| Dividends Paid | $1.8M0.0% | $1.8M-5.3% | $1.9M-32.1% | $2.8M-45.1% | $5.1M-3.8% | $5.3M+8.2% | $4.9M-3.9% | $5.1M |
| Share Buybacks | $0 | $0 | $0 | $0 | $0 | $0 | $0-100.0% | $1.6M |
MEI Financial Ratios
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | 16.6%-2.7pp | 19.3%+1.2pp | 18.1%+10.6pp | 7.5%-9.7pp | 17.2%-2.6pp | 19.8%+2.5pp | 17.3% |
| Operating Margin | N/A | -2.6%-3.8pp | 1.2%+0.7pp | 0.5%+12.2pp | -11.7%-10.8pp | -0.9%-4.1pp | 3.2%+6.1pp | -2.9% |
| Net Margin | N/A | -6.8%-2.8pp | -4.0%+0.3pp | -4.3%+8.9pp | -13.2%-7.2pp | -6.0%-5.5pp | -0.5%+6.5pp | -7.1% |
| Return on Equity | N/A | -2.4%-0.9pp | -1.5%+0.0pp | -1.5%+3.7pp | -5.2%-3.2pp | -2.0%-1.8pp | -0.2%+2.2pp | -2.5% |
| Return on Assets | N/A | -1.2%-0.5pp | -0.8%+0.0pp | -0.8%+2.0pp | -2.8%-1.7pp | -1.1%-1.0pp | -0.1%+1.2pp | -1.3% |
| Current Ratio | 2.37-0.0 | 2.41-0.1 | 2.55+0.1 | 2.50+0.1 | 2.40-0.4 | 2.84+0.1 | 2.75+0.4 | 2.35 |
| Debt-to-Equity | 0.48-0.0 | 0.50+0.0 | 0.49+0.0 | 0.47+0.0 | 0.460.0 | 0.470.0 | 0.46+0.1 | 0.40 |
| FCF Margin | N/A | 4.3%+9.0pp | -4.7%-12.2pp | 7.5%-2.1pp | 9.6%+1.4pp | 8.2%+28.1pp | -20.0%-18.9pp | -1.0% |
Similar Companies
Frequently Asked Questions
What is Methode Ele's annual revenue?
Methode Ele (MEI) reported $1.0B in total revenue for fiscal year 2026. This represents a -2.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Methode Ele's revenue growing?
Methode Ele (MEI) revenue declined by 2.8% year-over-year, from $1.0B to $1.0B in fiscal year 2026.
Is Methode Ele profitable?
No, Methode Ele (MEI) reported a net income of -$35.7M in fiscal year 2026, with a net profit margin of -3.5%.
What is Methode Ele's EBITDA?
Methode Ele (MEI) had EBITDA of $67.6M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Methode Ele have?
As of fiscal year 2026, Methode Ele (MEI) had $139.6M in cash and equivalents against $324.8M in long-term debt.
What is Methode Ele's gross margin?
Methode Ele (MEI) had a gross margin of 19.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Methode Ele's operating margin?
Methode Ele (MEI) had an operating margin of 0.9% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Methode Ele's net profit margin?
Methode Ele (MEI) had a net profit margin of -3.5% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
Does Methode Ele pay dividends?
Yes, Methode Ele (MEI) paid $0.22 per share in dividends during fiscal year 2026.
What is Methode Ele's return on equity (ROE)?
Methode Ele (MEI) has a return on equity of -5.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Methode Ele's free cash flow?
Methode Ele (MEI) generated $15.6M in free cash flow during fiscal year 2026. This represents a 202.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Methode Ele's operating cash flow?
Methode Ele (MEI) generated $38.0M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Methode Ele's total assets?
Methode Ele (MEI) had $1.3B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Methode Ele's capital expenditures?
Methode Ele (MEI) invested $22.4M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
How much does Methode Ele spend on research and development?
Methode Ele (MEI) invested $37.5M in research and development during fiscal year 2026.
What is Methode Ele's current ratio?
Methode Ele (MEI) had a current ratio of 2.37 as of fiscal year 2026, which is generally considered healthy.
What is Methode Ele's debt-to-equity ratio?
Methode Ele (MEI) had a debt-to-equity ratio of 0.48 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Methode Ele's return on assets (ROA)?
Methode Ele (MEI) had a return on assets of -2.7% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Methode Ele's Altman Z-Score?
Methode Ele (MEI) has an Altman Z-Score of 2.17, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Methode Ele's Piotroski F-Score?
Methode Ele (MEI) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Methode Ele's earnings high quality?
Methode Ele (MEI) has an earnings quality ratio of -1.06x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Methode Ele cover its interest payments?
Methode Ele (MEI) has an interest coverage ratio of 0.4x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Methode Ele?
Methode Ele (MEI) scores 31 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.